Develops cell therapies for chronic kidney disease and diabetes.
Jun 2026Revenue $818K/yrExpenses $178M/yr
No trendCash runway ≈ 6 months from Jun 2026
Figures by year
When will Prokidney be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $818K and expenses $178M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $893K | $166M | −$165M |
| Dec 2024 | $76.0K | $184M | −$184M |
| Dec 2023 | $0.00 | $152M | −$152M |
| Dec 2022 | $0.00 | $153M | −$153M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.